January 29, 2015 4:25 AM ET


Company Overview of NKT Therapeutics, Inc.

Company Overview

NKT Therapeutics, Inc., a biotechnology company, engages in developing therapeutics based on immune cells called natural killer T cells (NKT). It focuses to develop a pipeline of NKT based therapeutics to treat cancer, infectious diseases, autoimmune diseases, asthma, and atopic dermatitis. The company was incorporated in 2008 and is based in Waltham, Massachusetts.

1000 Winter Street

Suite 3900

Waltham, MA 02451

United States

Founded in 2008





Key Executives for NKT Therapeutics, Inc.

Chief Executive Officer
Co-founder and Member of Scientific Advisory Board
Vice President of Finance
Chief Medical Officer
Age: 58
Chief Scientifc Officer
Compensation as of Fiscal Year 2014.

NKT Therapeutics, Inc. Key Developments

NKT Therapeutics, Inc. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014

NKT Therapeutics, Inc. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 . Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States.

Similar Private Companies By Industry

Company Name Region
Therapeutic Peptides, Inc. United States
GlycoFi, Inc. United States
TNI Pharmaceuticals, Inc. United States
Centrillion Technology Holdings Corporation United States
ProChon Biotech Ltd. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NKT Therapeutics, Inc., please visit www.nktrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.